• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸腔积液的病因:对连续3000多例胸腔穿刺术的分析

Etiology of pleural effusions: analysis of more than 3,000 consecutive thoracenteses.

作者信息

Porcel José M, Esquerda Aureli, Vives Manuel, Bielsa Silvia

机构信息

Unidad de Enfermedades de la Pleura, Servicio de Medicina Interna, Hospital Universitario Arnau de Vilanova, Instituto de Investigación Biomédica de Lleida, Lleida, España.

Servicio de Análisis Clínicos, Hospital Universitario Arnau de Vilanova, Instituto de Investigación Biomédica de Lleida, Lleida, España.

出版信息

Arch Bronconeumol. 2014 May;50(5):161-5. doi: 10.1016/j.arbres.2013.11.007. Epub 2013 Dec 20.

DOI:10.1016/j.arbres.2013.11.007
PMID:24360987
Abstract

OBJECTIVE

To investigate the etiology of pleural effusions (PE) in adults and the accuracy of pleural fluid (PF) cytology and cultures in malignant and infectious PE, respectively.

PATIENTS AND METHODS

Retrospective analysis of all consecutive patients with PE undergoing diagnostic thoracentesis during the last 19 years in a university hospital.

RESULTS

The leading causes of PE among the 3,077 patients were: cancer (27%), heart failure (21%), pneumonia (19%), tuberculosis (9%), abdominal surgery (4%), pericardial diseases (4%) and cirrhosis (3%). Tuberculosis was the most common etiology in patients <34 years of age (52%), whereas heart failure predominated in octogenarians (45%). The most common primary tumors in malignant PE were lung (37%) and breast (16%). The overall accuracy of PF cytology was 59%, although it was significantly lower in mesotheliomas (27%) and squamous cell lung cancer (25%). In infectious PE, only 30% of cultures yielded positive results, a percentage which increased two-fold (66%) in purulent fluids (empyemas). Viridans streptococci were the most commonly isolated pathogens (25.5%). The sensitivity of solid media cultures of PF for Mycobacterium tuberculosis was low (18.5%).

CONCLUSIONS

Three-quarters of patients with PE in whom a diagnostic thoracentesis was indicated had cancer, heart failure, pneumonia or tuberculosis. PF cytology and cultures give false negative results in a significant number of cases.

摘要

目的

探讨成人胸腔积液(PE)的病因,以及分别在恶性和感染性PE中胸水(PF)细胞学检查和培养的准确性。

患者与方法

回顾性分析一所大学医院在过去19年中所有接受诊断性胸腔穿刺术的连续性PE患者。

结果

3077例患者中PE的主要病因如下:癌症(27%)、心力衰竭(21%)、肺炎(19%)、结核病(9%)、腹部手术(4%)、心包疾病(4%)和肝硬化(3%)。结核病是34岁以下患者中最常见的病因(52%),而心力衰竭在八旬老人中占主导地位(45%)。恶性PE中最常见的原发肿瘤是肺癌(37%)和乳腺癌(16%)。PF细胞学检查的总体准确率为59%,尽管在间皮瘤(27%)和肺鳞状细胞癌(25%)中显著较低。在感染性PE中,只有30%的培养结果呈阳性,在脓性液体(脓胸)中这一比例增加了两倍(66%)。草绿色链球菌是最常分离出的病原体(25.5%)。PF固体培养基培养对结核分枝杆菌的敏感性较低(18.5%)。

结论

在有指征进行诊断性胸腔穿刺术的PE患者中,四分之三患有癌症、心力衰竭、肺炎或结核病。PF细胞学检查和培养在相当多的病例中会得出假阴性结果。

相似文献

1
Etiology of pleural effusions: analysis of more than 3,000 consecutive thoracenteses.胸腔积液的病因:对连续3000多例胸腔穿刺术的分析
Arch Bronconeumol. 2014 May;50(5):161-5. doi: 10.1016/j.arbres.2013.11.007. Epub 2013 Dec 20.
2
Detection of Pleural Fluid Biochemistry Changes in Two Consecutive Thoracenteses for Differentiating Malignant from Benign Effusions.连续两次胸腔穿刺检测胸腔积液生化变化以鉴别恶性与良性胸腔积液
Arch Bronconeumol (Engl Ed). 2018 Jun;54(6):320-326. doi: 10.1016/j.arbres.2018.01.014. Epub 2018 Feb 26.
3
Pleural fluid amino-terminal brain natriuretic peptide in patients with pleural effusions.胸腔积液患者胸腔液中的氨基末端脑利钠肽。
Respir Care. 2013 Feb;58(2):313-9. doi: 10.4187/respcare.01818.
4
Pearls and myths in pleural fluid analysis.胸腔积液分析中的要点和误区。
Respirology. 2011 Jan;16(1):44-52. doi: 10.1111/j.1440-1843.2010.01794.x.
5
Exudative pleural effusion: effectiveness of pleural fluid analysis and pleural biopsy.渗出性胸腔积液:胸腔积液分析与胸膜活检的有效性
East Mediterr Health J. 2007 Jul-Aug;13(4):765-73.
6
[Pleural effusions--experience of Pneumo-phtisiology Hospital Tudor Vladimirescu--I: Clinical study].[胸腔积液——图多尔·弗拉迪米雷斯库肺结核病医院的经验——I:临床研究]
Pneumologia. 2008 Jul-Sep;57(3):138-46.
7
Diagnostic efficacy of pleural biopsy as compared with that of pleural fluid examination.胸膜活检与胸腔积液检查的诊断效能比较。
Mod Pathol. 1991 May;4(3):320-4.
8
Analysis of pleural effusions in acute pulmonary embolism: radiological and pleural fluid data from 230 patients.急性肺栓塞中胸腔积液的分析:230例患者的放射学和胸腔积液数据
Respirology. 2007 Mar;12(2):234-9. doi: 10.1111/j.1440-1843.2006.01026.x.
9
Osteopontin is upregulated in malignant and inflammatory pleural effusions.骨桥蛋白在恶性和炎症性胸腔积液中上调。
Respirology. 2009 Jul;14(5):716-22. doi: 10.1111/j.1440-1843.2009.01536.x. Epub 2009 May 19.
10
[Pleural fluid interferon-gamma (IFN-gamma) measurement as a diagnostic tool in tuberculous pleurisy].[胸腔积液干扰素-γ(IFN-γ)检测作为结核性胸膜炎的诊断工具]
Pneumonol Alergol Pol. 2008;76(4):237-45.

引用本文的文献

1
Diagnostic Efficacy of C-Reactive Protein in Differentiating Various Causes of Exudative Pleural Effusion: Disease Research Should Not Be Exclusive to the Wealthy.C反应蛋白在鉴别渗出性胸腔积液各种病因中的诊断效能:疾病研究不应只为富人服务。
Adv Respir Med. 2025 Aug 5;93(4):29. doi: 10.3390/arm93040029.
2
Effect of intrapleural anti-Vascular Endothelial Growth Factor (VEGF) associated with nab paclitaxel in a murine model of malignant pleural effusion.胸膜内注射抗血管内皮生长因子(VEGF)联合纳米白蛋白结合型紫杉醇在恶性胸腔积液小鼠模型中的作用
BMC Cancer. 2025 Aug 2;25(1):1261. doi: 10.1186/s12885-025-14622-x.
3
Reflections on the applicability of palliative thoracentesis in Primary Care.
关于姑息性胸腔穿刺术在初级保健中的适用性的思考。
Aten Primaria. 2025 Jul 17;57(10):103336. doi: 10.1016/j.aprim.2025.103336.
4
Influence of age and sex on the diagnostic accuracy of pleural fluid carcinoembryonic antigen for malignant pleural effusion: a analysis.年龄和性别对恶性胸腔积液患者胸水癌胚抗原诊断准确性的影响:一项分析。
Front Oncol. 2025 May 6;15:1549621. doi: 10.3389/fonc.2025.1549621. eCollection 2025.
5
Malignant Pleural Effusion: Palliative Managements and Indication for Pleurodesis Based on Survival Scores.恶性胸腔积液:基于生存评分的姑息治疗及胸膜固定术指征
J Surg Oncol. 2025 Jul;132(1):35-44. doi: 10.1002/jso.28156. Epub 2025 May 20.
6
Exosomal miR-182-5p is a potential diagnostic marker for malignant pleural effusion.外泌体miR-182-5p是恶性胸腔积液的一种潜在诊断标志物。
Transl Lung Cancer Res. 2025 Apr 30;14(4):1138-1148. doi: 10.21037/tlcr-2024-1205. Epub 2025 Apr 16.
7
Interleukin -39 Expression in Pleural Effusion and Its Diagnostic Value for Tuberculous Pleurisy.白细胞介素-39在胸腔积液中的表达及其对结核性胸膜炎的诊断价值
J Inflamm Res. 2025 Apr 5;18:4755-4770. doi: 10.2147/JIR.S488017. eCollection 2025.
8
Efficacy and safety of pleurodesis for lung cancer patients with interstitial lung disease.胸膜固定术治疗合并间质性肺疾病的肺癌患者的疗效与安全性
J Thorac Dis. 2025 Feb 28;17(2):687-694. doi: 10.21037/jtd-24-1541. Epub 2025 Feb 27.
9
Diagnostic Utility of Pleural C-Reactive Protein and Procalcitonin for Parapneumonic Pleural Effusion: A Head-to-Head Comparison Study.胸腔C反应蛋白和降钙素原在类肺炎性胸腔积液中的诊断效用:一项直接比较研究
Infect Drug Resist. 2025 Feb 17;18:919-927. doi: 10.2147/IDR.S493610. eCollection 2025.
10
Biological and cytological-morphological assessment of tuberculous pleural effusions.结核性胸腔积液的生物学及细胞形态学评估
Rom J Morphol Embryol. 2024 Oct-Dec;65(4):693-712. doi: 10.47162/RJME.65.4.17.